A Study of TNM001 in Chinese Healthy Preterm and Term Infants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The purpose of this clinical trial is to evaluate the safety, tolerability and pharmacokinetics (PK) profile of TNM001 injection in healthy preterm and term infants. The main questions it aims to answer are: * the safety and tolerability of TNM001 injection * the pharmacokinetic (PK) profile of TNM001
Epistemonikos ID: 495fceba0173f89eef67eeb09234dedfb49b9746
First added on: May 14, 2024